Navigation Links
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
Date:1/23/2009

LA JOLLA, Calif., Jan. 23 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc., formerly known as Duska Therapeutics, Inc., (OTC Bulletin Board: DSKA) announced today that it will host a scientific briefing on Thursday, January 29, 2009, at 12:00 p.m. EST in New York City.

The keynote speaker will be Jonathan S. Stamler, MD, the George Barth Geller Professor for Research in Cardiovascular Diseases and a Professor of Medicine and of Biochemistry at Duke University Medical Center in Durham, North Carolina. Dr. Stamler will review his research work at Duke University, which focuses on the regulatory role of nitric oxide (NO) in the cardiovascular system. In particular, Dr. Stamler will outline the rationale behind the development of NO-based therapeutic modality in the management of patients with heart failure. The risk of sudden cardiac death in heart failure patients is six to nine times greater than that of the general population. Heart failure is responsible for 280,000 deaths annually in the US.

Dr. Stamler's presentation will be preceded by a short corporate overview by Cordex's chief executive officer, James S. Kuo, MD, MBA, and an update by the Company's chief scientific officer, Amir Pelleg, PhD, on the Company's lead drug candidate, ATPace, for the treatment and diagnosis of cardiac arrhythmias. Cordex expects to initiate a pivotal Phase 3 clinical trial with ATPace. The Phase 3 protocol is currently under consideration by the FDA under a Special Protocol Assessment provision.

Cordex's event will be held at the Yale Club in New York City. A buffet lunch will be provided beginning at 11:30 a.m. EST. Due to meeting room size limitations, in person attendance is by invitation only. To request an invitation, please call Redington Inc. at (212) 926-1733.

A webcast of the presentation can be accessed by any registered participants and will be made available at '/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Axikin Pharmaceuticals Spins out of Actimis
2. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
3. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
4. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
5. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
6. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
7. Cumberland Pharmaceuticals Appoints Lee Product Director
8. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
9. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Emerson Resources Inc. , ... Charles Signorino, the Company’s Chief Executive Officer and Chairman ... 32 years of service. As part of Emerson Resources’ ... has been named as Dr. Signorino’s successor. , ... industry, having made a significant contribution to the field ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013  Synthetic Biologics, ... the prevention and treatment of serious infectious diseases, announced today ... at the 2 nd Annual Marcum LLP MicroCap Conference ... City at the Grand Hyatt Hotel. Mr. Riley ... A live webcast of Synthetic Biologics, presentation can be ...
(Date:5/21/2013)... May 21, 2013 Bed bugs have become ... My Cleaning Products, many turn to chemical-based pesticides for help ... health and environmental risks those solutions present, the company advised ... Bug Bully instead. , According to My Cleaning Products, ... they used to be. It shared that the pests have ...
(Date:5/21/2013)... May 21, 2013 NANONEX CORPORATION, ... solutions , today announced the successful delivery and ... system, the NX-M200B, to a major Japanese manufacturing ... a fully-automated, production-ready, advanced nanoimprint lithography tool that ... wafer and substrate sizes and types. Based on ...
Breaking Biology Technology:Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... Funds will extend the National ... Honolulu, HI ... $2.8 million in research funding from the National Cancer Institute (NCI) to continue the National ... years. , , , , ,Since 2002, PHRI has participated in the NLST, a research ...
... Stemedica ... today that it has been granted a license by the State of California,s Food ... Manufacturing License recognizes Stemedica as being compliant with California law and the applicable provisions ... ...
... , ... DeSilva + Phillips, Media Investment Bankers, has ... M&A practice. Formerly CEO of IncumediX and COO/CSO at MediServe Information ... on over 140 transactions, including acquisitions, technology license and partnership deals, ...
Cached Biology Technology:Pacific Health Research Institute Awarded $2.8 Million in Research Funding 2Pacific Health Research Institute Awarded $2.8 Million in Research Funding 3Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 2Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 3DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice 2DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice 3
(Date:5/22/2013)... novel technique that can detect molecular variants in chemical ... of the most important, though time-consuming, processes in analytical ... Nature , post-doctoral researcher David Patterson, Professor of ... Center for Free-Electron Laser Science (CFEL) in Hamburg, Germany ... to identify molecular variants apart, and to determine how ...
(Date:5/22/2013)... of potential environmental and human health effects from ... year has led scientists to recommend stronger government ... lithium-ion (Li-ion) battery materials. That,s the conclusion of ... Environmental Science & Technology . , Oladele A. ... have become mainstays for powering everything from smart ...
(Date:5/22/2013)... screening for prostate cancer could become as easy for ... to UC Irvine research published today in the ... more than a decade of work, UC Irvine chemists ... markers for prostate cancer in urine, meaning that the ... and at dramatically lower cost. The same technology could ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... Aware, Inc. (Nasdaq: AWRE ), a leading supplier ... call to discuss the company,s operating results for the first ... Eastern Time. CEO Michael Tzannes and CFO Rick Moberg will ... Thomson and can be accessed on the Investor Relations page ...
... Park, Md. -- DNA sequencing is the next frontier ... and affordable, it is increasingly available to small laboratories. ... faster rate than ever before. However, the computing ... still has some catching up to do. Large ...
... We have the will but do we have the technology? ... being held May 13 to 15, 2009 at McMaster University ... climate change and global warming. Among the guest speakers ... of Canada and former Premier of Manitoba. He will ...
Cached Biology News:Aware, Inc. Announces Q1 '09 Earnings Conference Call 2A genomic CluE for cloud computing 2A genomic CluE for cloud computing 3
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
...
Biology Products: